Patent holdings for IPC class A61K 31/44

Total number of patents in this class: 7499

10-year publication summary

494
432
476
447
405
362
379
381
377
244
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Merck Sharp & Dohme LLC
3733
101
Bristol-myers Squibb Company
4757
86
Merck Sharp & Dohme Corp.
2183
86
Boehringer Ingelheim International GmbH
4479
72
Novartis AG
10169
69
The Regents of the University of California
20902
66
Arcutis Biotherapeutics, Inc.
126
59
F. Hoffmann-La Roche AG
7798
48
Vertex Pharmaceuticals Incorporated
1577
46
Chiesi Farmaceutici S.p.A.
952
43
Takeda Pharmaceutical Company Limited
2700
42
Hoffmann-La Roche Inc.
3841
36
Pfizer Inc.
3418
33
Gilead Sciences, Inc.
2247
32
Merck Patent GmbH
5747
31
Board of Regents, The University of Texas System
6172
31
Janssen Pharmaceutica N.V.
3147
30
Vanderbilt University
2030
30
The General Hospital Corporation
4890
29
Corteva Agriscience LLC
2649
29
Other owners 6500